Skip to main content

Alternative names

ACH, ACLS, AIS, ANDR_HUMAN, AR, AR8, ASV, AW259666, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Atherosclerosis, susceptibility to, included, Avian sarcoma virus, BBDS, BEK, BEK fibroblast growth factor receptor, BFGFR, BFR1, Basic fibroblast growth factor receptor 1, Beta-interferon, C SRC, C-SRC kinase, CD 333, CD 334, CD309, CD309 antigen, CD331, CD332, CD332 antigen, CD333 antigen, CD334 antigen, CDNA FLJ14219 fis clone NT2RP3003800 highly similar to Rattus norvegicus tyrosine protein kinase pp60 c src mRNA, CEK, CEK 2, CEK3, CFD1, CSK_HUMAN, CYTOPLASMIC TYROSINE KINASE, Cellular Yes 1 protein, Chy, Craniofacial dysostosis 1, Csk A, Cytosolic NADP-isocitrate dehydrogenase, DHTR, DKFZp686N23123, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 2.7.10.1, EC 2.7.10.2, ECT1, ER, ER-alpha, ER-beta, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESTR B, Epididymis luminal protein 216, Epididymis secretory protein Li 26, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen resistance, included, FGF receptor, FGFBR, FGFR1/PLAG1 fusion, FGFR1_HUMAN, FGFR2_HUMAN, FGFR3_HUMAN, FGFR4_HUMAN, FLG, FLK-1, FLK1, mouse, homolog of, FLT, FLT-2, FLT41, FRT, Fetal liver kinase 1, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 3, Fibroblast growth factor receptor 3 (achondroplasia thanatophoric dwarfism), Fibroblast growth factor receptor 4, Fibroblast interferon, Flt-1, Fms related tyrosine kinase 1, Fms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), Fms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor, Fms related tyrosine kinase 4, Fms-like gene, Fms-like tyrosine kinase 1, Fms-like tyrosine kinase 2, Fms-like tyrosine kinase 4, GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GR, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Grl1, HBGFR, HDL cholesterol, augmented response of, to hormone replacement, included, HEL-216, HEL-S-26, HH2, HRTFDS, HSFGFR3EX, HUMARA, HYSP1, HsT441, ICDH, IDCD, IDH, IDH1, IDHC_HUMAN, IDP, IDPC, IFB, IFF, IFN-beta, IFNB 1, IFNB_HUMAN, Interferon beta, Interferon beta 1 fibroblast, Interferon beta precursor, Isocitrate dehydrogenase (NADP(+)) 1 cytosolic, Isocitrate dehydrogenase 1 (NADP+) soluble, Isocitrate dehydrogenase [NADP] cytoplasmic, JTK 2, JTK 4, JWS, Jackson Weiss syndrome, K-sam, KAL2, KD, KGFR, KRD1, Kdr, Kennedy disease (KD), Keratinocyte growth factor receptor, Keratinocyte growth factor receptor 2, Kinase insert domain receptor, Kinase insert domain receptor (a type III receptor tyrosine kinase), LMPH1A, Ly73, MFR 3, MGC112926, MGC117393, MGC154049, MGC20292, MGC96956, Myocardial infarction, susceptibility to, included, N-SAM, NADP dependent isocitrate dehydrogenase cytosolic, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, NR3A1, NR3A2, NR3C4, Neuronal CSRC tyrosine specific protein kinase, Neuronal SRC, Neuronal proto-oncogene tyrosine-protein kinase Src, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), OGD, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000174476, OTTHUMP00000174477, Oncogene GLI3, Oncogene SRC, Oxalosuccinate decarboxylase, PAP A, PAPB, PCL, PICD, PPD IV, Protein tyrosine kinase, Protein-tyrosine kinase CYL, Protein-tyrosine kinase receptor flk-1, Proto oncogene tyrosine protein kinase, Proto oncogene tyrosine protein kinase YES, Proto-oncogene c-Fgr, Proto-oncogene c-Src, Proto-oncogene c-Yes, Proto-oncogene tyrosine-protein kinase Src, Protooncogene SRC, Protooncogene SRC Rous sarcoma, RNESTROR, SAM 3, SBMA, SMAX1, SRC Oncogene, SRC proto oncogene non receptor tyrosine kinase, SRC_HUMAN, Soluble VEGF receptor 1 14, Soluble VEGFR1 variant 2, Soluble VEGFR1 variant 21, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), TFM, TK14, TK25, TKF, Testicular Feminization (TFM), Transcriptional activator GLI3, Transcriptional repressor GLI3R, Tyrosine kinase JTK 4, Tyrosine kinase growth factor receptor, Tyrosine kinase pp60c src, Tyrosine kinase related to fibroblast growth factor receptor, Tyrosine protein kinase SRC 1, Tyrosine-protein kinase CSK, Tyrosine-protein kinase FRT, Tyrosine-protein kinase Yes, Tyrosine-protein kinase receptor FLT, Tyrosine-protein kinase receptor FLT4, Tyrosylprotein kinase, V src sarcoma (Schmidt Ruppin A 2) viral oncogene homolog (avian), VEGFR, VEGFR-1, VEGFR-2, VEGFR-3, VGFR1_HUMAN, VGFR2_HUMAN, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor receptor 2, Vascular endothelial growth factor receptor 3, Vascular endothelial growth factor vascular permeability factor receptor, Vascular permeability factor receptor, Vascular permeability factor receptor 1, Viral oncogene yes 1 homolog 1, YES proto oncogene 1, Src family tyrosine kinase, YES1 proto oncogene, Src family tyrosine kinase, YES_HUMAN, Yamaguchi sarcoma oncogene, Yes 1, Z FGFR 3, Zinc finger protein GLI 3, androgen receptor splice variant 4b, bFGF-R-1, bacteria-expressed kinase, c Yes, c-src tyrosine kinase, fc13h 10, fibroblast growth factor receptor 1, fms-related tyrosine kinase 2, glucocorticoid nuclear receptor variant 1, heparin-binding growth factor receptor, hydroxyaryl-protein kinase, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), p60-Src, p60c-src, p61-Yes, pp60c-src, protein tyrosine kinase, receptor like 14, soluble FGFR4 variant 4, soluble VEGFR2, v src avian sarcoma (Schmidt Ruppin A2) viral oncogene homolog, v src sarcoma (Schmidt Ruppin A 2) viral oncogene homolog avian, v yes 1 Yamaguchi sarcoma viral oncogene homolog 1, zgc:154049

Target type

Biochemicals

We found 1 product in 1 category

Biochemicals

Biological action

Chemical type

Search our catalogue for 'PD 173074' (1)

Products